痛风与痴呆临床关联的影响:韩国全国人群队列研究
该回顾性队列研究从韩国国民健康保险服务(NHIS)全国样本队列数据库选取5,052例痛风患者和25,260例年龄性别匹配对照,评估痴呆发病风险。痛风患者总体痴呆风险比为0.79(95%CI 0.62-1.00),阿尔茨海默病风险显著降低(HR 0.73,95%CI 0.54-0.98);老年男性亚组中痛风与总体痴呆(HR 0.71,95%CI 0.52-0.97)及阿尔茨海默病(HR 0.67,95%CI 0.46-0.97)风险呈负相关,而非老年男性亚组血管性痴呆风险比为2.31(95%CI 1.02-5.25)。
要点
- 痛风患者总体痴呆风险比为0.79(95%CI 0.62-1.00),阿尔茨海默病风险显著降低(HR 0.73,95%CI 0.54-0.98)。
- 老年男性亚组中痛风与总体痴呆(HR 0.71,95%CI 0.52-0.97)及阿尔茨海默病(HR 0.67,95%CI 0.46-0.97)风险呈负相关。
- 非老年男性亚组中痛风患者血管性痴呆风险比为2.31(95%CI 1.02-5.25)。
核心结论
- 痛风降低阿尔茨海默病型痴呆的发病风险,尤其在老年患者中。
- 痛风与痴呆风险的关联可能因年龄和疾病病程而异。
研究设计与样本
- 回顾性队列研究,从韩国国民健康保险服务(NHIS)全国样本队列数据库选取5,052例痛风患者和25,260例年龄性别匹配对照。
- 通过审查NHIS记录评估痴呆发病率和风险,并按年龄组(<65岁或≥65岁,以65岁为标准年龄划分老年与非老年组)和性别进行亚组分析。
主要发现
- 随访期间痛风队列81例、对照队列558例发生痴呆,痛风患者平均随访4.38年,对照平均随访4.94年。
- 调整年龄、性别、家庭收入和合并症后,痛风患者总体痴呆风险比为0.79(95%CI 0.62-1.00),阿尔茨海默病风险比为0.73(95%CI 0.54-0.98)。
- 按年龄和性别分层亚组分析中,老年男性组痛风与总体痴呆风险呈负相关(HR 0.71,95%CI 0.52-0.97),与阿尔茨海默病风险呈负相关(HR 0.67,95%CI 0.46-0.97)。
- 年龄性别调整分析显示,非老年男性组痛风患者血管性痴呆风险比为2.31(95%CI 1.02-5.25)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hyperuricemia might have neuroprotective or neurodegenerative effects on dementia via oxidative stress or inflammatory response regulation. Few studies have explored the association of hyperuricemia or gout with dementia. This retrospective cohort study aimed to investigate the association between gout and dementia in Korea. METHODS: Altogether, 5,052 gout patients and 25,260 age- and sex-matched controls were selected from the National Health Insurance Service (NHIS)-National Sample Cohort database. The incidence and risk of dementia were evaluated by reviewing the NHIS record. We also performed a subgroup analysis according to age group (age <65 or ≥65 years) using the standard age of 65 years for elderly and nonelderly groups and sex. RESULTS: During follow-up, 81 and 558 participants in the gout and control cohorts developed dementia, respectively. The mean follow-up duration was 4.38 years in gout patients and 4.94 years in controls. Gout patients had a hazard ratio (HR) of 0.79 for overall dementia (95% confidence interval [95% CI] 0.62-1.00) and significantly lower Alzheimer's disease risk (HR 0.73 [95% CI 0.54-0.98]) after adjusting for age, sex, household income, and comorbidities. In subgroup analysis stratified by age and sex, the inverse association between gout and the risk of overall dementia (HR 0.71 [95% CI 0.52-0.97]) and Alzheimer's disease (HR 0.67 [95% CI 0.46-0.97]) were observed in the elderly male group. On the other hand, age- and sex-adjusted analysis showed that the HR for vascular dementia of gout patients was 2.31 (95% CI 1.02-5.25) in the nonelderly male group. CONCLUSION: Gout decreased the risk of incident Alzheimer's disease-type dementia, especially in elderly patients. The association between gout and dementia risk may differ according to age and disease duration.
引用
- Kim JH, Yim DH, Choi IA, et al. Impact of Clinical Association Between Gout and Dementia: A Nationwide Population-Based Cohort Study in Korea. Arthritis Care Res (Hoboken). 2022. PMID: 35604886. doi:10.1002/acr.24959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。